Afatinib is under development in several solid tumors including non-small cell lung cancer (NSCLC) and head and neck cancer.
Afatinib被开发用于治疗多种实体肿瘤，包括非小细胞肺癌(NSCLC)及头颈癌。
2
The LUX trial program is a comprehensive and robust program that comprises more than 10 trials conducted across the globe, investigating afatinib in a variety of different solid tumor types.